ApoA-I mimetic peptide presents an amphipathic sequence engineered to reproduce structural motifs of lipid-binding proteins. Hydrophobic and charged residues promote helix formation and membrane-association modeling. Researchers study its dynamic conformational states to understand lipid-peptide interactions. Applications include biophysical studies, structural mimicry, and peptide-material development.
CAT No: R2504
CAS No:221882-20-8
Synonyms/Alias:ApoA-I mimetic peptide;221882-20-8;
ApoA-I mimetic peptide is a synthetic peptide designed to replicate the structural and functional properties of apolipoprotein A-I, the principal protein component of high-density lipoprotein (HDL) in plasma. Characterized by its amphipathic helical domains, this peptide exhibits a strong affinity for lipid binding and is widely studied for its role in modulating lipid metabolism and reverse cholesterol transport. Its engineered sequence aims to emulate the cholesterol efflux and anti-inflammatory functions of native ApoA-I, making it a valuable tool in cardiovascular and metabolic research. The ability to mimic HDL's protective effects has positioned ApoA-I mimetic peptides as essential reagents in studies investigating lipid homeostasis, oxidative stress, and atherogenesis.
Lipid metabolism research: ApoA-I mimetic peptides are extensively utilized in mechanistic studies focused on lipid transport and metabolism. By simulating the interaction between apolipoprotein A-I and phospholipids, these peptides enable researchers to dissect the molecular pathways involved in cholesterol efflux from peripheral cells to HDL particles. Their use facilitates the evaluation of HDL functionality and the investigation of key steps in reverse cholesterol transport, offering insights into the regulation of plasma lipid profiles and the prevention of lipid accumulation in vascular tissues.
Atherosclerosis modeling: In experimental models of atherogenesis, ApoA-I mimetic peptides provide a unique tool for probing the molecular mechanisms underlying plaque formation and progression. Their ability to promote cholesterol efflux and modulate inflammatory responses allows researchers to assess the impact of HDL-mimicking interventions on arterial wall biology. These peptides are employed in in vitro and in vivo systems to evaluate their effects on foam cell formation, macrophage lipid handling, and the overall dynamics of atherosclerotic lesion development.
Inflammation and oxidative stress studies: The anti-inflammatory and antioxidant properties attributed to ApoA-I and its mimetics have prompted their widespread use in cellular and biochemical assays investigating the interplay between lipid metabolism and immune responses. Researchers leverage these peptides to explore their influence on cytokine production, oxidative modification of lipids, and the attenuation of pro-inflammatory signaling pathways. Such studies are instrumental in elucidating the protective mechanisms conferred by HDL and its analogs against oxidative and inflammatory insults.
Peptide structure-function analysis: ApoA-I mimetic peptides serve as versatile models for structure-activity relationship (SAR) studies, enabling detailed examination of the structural determinants critical for HDL binding, lipid solubilization, and biological activity. By introducing specific sequence modifications or employing labeled analogs, investigators can delineate the contributions of individual amino acid residues and helical domains to the peptide's biophysical and functional properties. These insights inform the rational design of next-generation mimetics with enhanced efficacy and stability.
Analytical assay development: The unique amphipathic nature and lipid-binding capabilities of ApoA-I mimetic peptides make them valuable standards or controls in the development and validation of analytical assays targeting HDL functionality. Their defined sequence and reproducible activity support the calibration of cholesterol efflux assays, lipoprotein binding studies, and high-throughput screening platforms aimed at identifying modulators of HDL-mediated processes. By providing a reliable reference, these peptides help ensure assay consistency and facilitate inter-laboratory comparability in lipid research.
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More